Our prior work showed that IGF2BP3 is required for B-ALL cell survival and overexpression in BM of mice leads to a pathologic expansion of HSPCs [22]. This evidence concerns the gene IGF2BP3 and precursor B-cell acute lymphoblastic leukemia.